Clinic
University of California Irvine
University of California Irvine was paid $39.98M by Medicaid between Jan 2018 and Dec 2024, across 214 billing codes. Its largest line is T1015, a visit at a community health center or clinic (one all-in rate) — 82% of everything it billed.
33Billing provider infoUNIVERSITY OF CALIFORNIA IRVINE
SANTA ANA, CA 92701
SANTA ANA, CA 92701
33aNPI1851325906assigned 07/11/2006
33bProvider typeInfusion Therapy Clinic/Center
28Total paid$39.98M
24GClaims706,983
24DCodes billed214
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Infusion Therapy Clinic/Center providers in California
Rank by total paid#2 of 11
Median peer was paid$20K
This provider vs. median2,008×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 62,713 | $4.01M | |
| 2019 | 66,902 | $3.69M | |
| 2020 | 93,230 | $5.52M | |
| 2021 | 127,102 | $7.07M | |
| 2022 | 103,452 | $5.54M | |
| 2023 | 125,041 | $6.66M | |
| 2024incomplete | 128,543 | $7.49M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 82% | 232,679 | 214,856 | $32.81M |
| 00003 | Internal/system code - not a standard HCPCS code | 4.0% | 7,152 | 6,627 | $1.60M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 3.4% | 124,726 | 108,208 | $1.37M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 1.9% | 50,286 | 43,440 | $773K |
| 96156 | 1.4% | 19,143 | 18,532 | $560K | |
| H1001 | Prenatal care, at-risk enhanced service; antepartum management | <1% | 2,305 | 1,859 | $197K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 9,084 | 8,177 | $197K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 9,046 | 8,002 | $192K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,634 | 4,707 | $171K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 6,789 | 5,851 | $129K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 4,619 | 4,089 | $125K |
| 59425 | <1% | 2,050 | 1,391 | $121K |
202 more codes
| 96158 | <1% | 5,050 | $118K | |
| 90686 | <1% | 14,837 | $91K | |
| 0012A | <1% | 1,530 | $78K | |
| 0011A | <1% | 1,521 | $64K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 1,945 | $63K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 2,283 | $60K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 1,242 | $55K |
| 0001A | <1% | 1,196 | $54K | |
| 0002A | <1% | 1,002 | $52K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 1,031 | $51K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 8,581 | $47K |
| 97802 | <1% | 1,116 | $45K | |
| 90670 | <1% | 7,535 | $43K | |
| 97811 | <1% | 2,969 | $42K | |
| 97810 | <1% | 3,017 | $42K | |
| 90715 | <1% | 1,729 | $41K | |
| 90677 | <1% | 1,588 | $38K | |
| 90651 | <1% | 1,023 | $35K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 13,144 | $30K |
| G2025 | Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only | <1% | 1,607 | $28K |
| 97803 | <1% | 1,154 | $28K | |
| G9920 | Screening performed and negative | <1% | 6,106 | $27K |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | <1% | 6,273 | $26K |
| 59430 | <1% | 289 | $24K | |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 466 | $24K |
| 96151 | <1% | 2,336 | $24K | |
| 0064A | <1% | 436 | $22K | |
| 90750 | <1% | 149 | $22K | |
| 96167 | <1% | 559 | $20K | |
| 90698 | <1% | 4,023 | $19K | |
| 96159 | <1% | 2,696 | $18K | |
| 0072A | <1% | 322 | $17K | |
| H1000 | Prenatal care, at-risk assessment | <1% | 111 | $17K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | <1% | 184 | $17K |
| D0150 | Comprehensive oral evaluation - new or established patient | <1% | 431 | $16K |
| 90633 | <1% | 2,624 | $16K | |
| 0071A | <1% | 354 | $16K | |
| D1110 | Prophylaxis - adult | <1% | 274 | $16K |
| 99051 | <1% | 3,382 | $15K | |
| 0004A | <1% | 293 | $15K | |
| D1120 | Dental cleaning, child | <1% | 644 | $15K |
| 81003 | <1% | 23,159 | $15K | |
| 90681 | <1% | 2,669 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 2,033 | $13K |
| D0120 | Dental checkup, returning patient | <1% | 467 | $12K |
| 90656 | <1% | 1,397 | $11K | |
| 90744 | <1% | 1,977 | $11K | |
| 99385 | <1% | 138 | $9K | |
| T1027 | Family training and counseling for child development, per 15 minutes | <1% | 744 | $8K |
| D0210 | Intraoral - complete series of radiographic images | <1% | 188 | $8K |
| 81025 | <1% | 3,032 | $7K | |
| 90697 | <1% | 2,194 | $7K | |
| 90716 | <1% | 867 | $7K | |
| H2015 | Community support for mental illness or disability, per 15 minutes | <1% | 706 | $7K |
| 90707 | <1% | 775 | $7K | |
| D1206 | Topical application of fluoride varnish | <1% | 631 | $6K |
| D0145 | Oral evaluation for a patient under three years of age | <1% | 180 | $6K |
| 90658 | <1% | 467 | $6K | |
| 90619 | <1% | 254 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 887 | $5K |
| 90710 | <1% | 825 | $5K | |
| 90700 | <1% | 512 | $5K | |
| 92551 | <1% | 956 | $5K | |
| 90648 | <1% | 489 | $4K | |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | <1% | 2,988 | $4K |
| 90734 | <1% | 793 | $4K | |
| D0230 | Intraoral - periapical each additional radiographic image | <1% | 253 | $4K |
| 85018 | <1% | 3,521 | $4K | |
| 0054A | <1% | 66 | $3K | |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 79 | $3K |
| 93000 | <1% | 201 | $3K | |
| 96127 | <1% | 2,503 | $3K | |
| 99401 | <1% | 272 | $3K | |
| 90696 | <1% | 406 | $3K | |
| 96170 | <1% | 138 | $3K | |
| 99386 | <1% | 25 | $3K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 2,033 | $3K |
| D2392 | Resin-based composite - two surfaces, posterior, primary or permanent | <1% | 43 | $3K |
| 0124A | <1% | 40 | $3K | |
| 90649 | <1% | 604 | $2K | |
| 96150 | <1% | 138 | $2K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 144 | $2K |
| G8431 | Screening for depression is documented as being positive and a follow-up plan is documented | <1% | 123 | $2K |
| 90662 | <1% | 314 | $1K | |
| S9445 | Patient education, not otherwise classified, non-physician provider, individual, per session | <1% | 145 | $1K |
| H1003 | Prenatal care, at-risk enhanced service; education | <1% | 72 | $1K |
| 99234 | <1% | 12,157 | $1K | |
| 90685 | <1% | 141 | $1K | |
| 90480 | <1% | 70 | $1K | |
| H2027 | Psychoeducational service, per 15 minutes | <1% | 95 | $1K |
| 85999 | <1% | 316 | $951.16 | |
| 90620 | <1% | 144 | $893.46 | |
| D0272 | Bitewings - two radiographic images | <1% | 80 | $814.00 |
| 99443 | <1% | 69 | $777.27 | |
| 85610 | <1% | 1,034 | $740.61 | |
| G0008 | Administration of influenza virus vaccine | <1% | 393 | $617.34 |
| D0274 | Bitewings - four radiographic images | <1% | 28 | $561.60 |
| 90672 | <1% | 184 | $549.00 | |
| 82947 | <1% | 564 | $456.42 | |
| 99173 | <1% | 591 | $449.80 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 34 | $413.54 |
| 99442 | <1% | 43 | $367.84 | |
| D0220 | Intraoral - periapical first radiographic image | <1% | 26 | $284.00 |
| 91322 | <1% | 24 | $218.88 | |
| Q3014 | Telehealth originating site facility fee | <1% | 1,071 | $195.25 |
| G0071 | Payment for communication technology-based services for 5 minutes or more of a virtual (non-face-to-face) communication between an rural health clinic (rhc) or federally qualified health center (fqhc) practitioner and rhc or fqhc patient, or 5 minutes or more of remote evaluation of recorded video and/or images by an rhc or fqhc practitioner, occurring in lieu of an office visit; rhc or fqhc only | <1% | 14 | $163.94 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 333 | $103.95 |
| 99070 | <1% | 45 | $101.81 | |
| 96152 | <1% | 55 | $78.74 | |
| 96154 | <1% | 36 | $64.65 | |
| 81001 | <1% | 1,052 | $62.00 | |
| 99381 | <1% | 40 | $60.29 | |
| G0009 | Administration of pneumococcal vaccine | <1% | 17 | $57.06 |
| 90461 | <1% | 236 | $45.00 | |
| 80053 | Comprehensive metabolic panel | <1% | 2,136 | $40.00 |
| J3490 | Unclassified drugs | <1% | 235 | $39.86 |
| 96160 | <1% | 4,478 | $20.10 | |
| 90660 | <1% | 23 | $18.00 | |
| 90746 | <1% | 24 | $4.69 | |
| 81002 | <1% | 25 | $3.44 | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | <1% | 438 | $2.23 |
| Z1034 | 0% | 10,807 | $0.00 | |
| 83690 | 0% | 438 | $0.00 | |
| 3074F | 0% | 2,257 | $0.00 | |
| D0603 | 0% | 44 | $0.00 | |
| 0250 | 0% | 585 | $0.00 | |
| 96161 | 0% | 611 | $0.00 | |
| 0301 | 0% | 59 | $0.00 | |
| 83605 | 0% | 95 | $0.00 | |
| 3075F | 0% | 470 | $0.00 | |
| 84484 | 0% | 315 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 2,407 | $0.00 |
| Z1032 | 0% | 655 | $0.00 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 0% | 27 | $0.00 |
| 3079F | 0% | 477 | $0.00 | |
| 0258 | 0% | 79 | $0.00 | |
| 71045 | Radiologic examination, chest; single view | 0% | 375 | $0.00 |
| 0306 | 0% | 364 | $0.00 | |
| 83735 | 0% | 786 | $0.00 | |
| Z6402 | 0% | 12 | $0.00 | |
| 96375 | Therapeutic injection; each additional sequential IV push | 0% | 308 | $0.00 |
| 99283 | Emergency room visit (moderate) | 0% | 2,556 | $0.00 |
| 0324 | 0% | 128 | $0.00 | |
| Z1038 | 0% | 295 | $0.00 | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 0% | 48 | $0.00 |
| Z6410 | 0% | 240 | $0.00 | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 0% | 677 | $0.00 |
| 0370 | 0% | 12 | $0.00 | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 0% | 126 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 0% | 458 | $0.00 |
| 85730 | 0% | 426 | $0.00 | |
| 0270 | 0% | 524 | $0.00 | |
| 0352 | 0% | 45 | $0.00 | |
| 0420 | 0% | 99 | $0.00 | |
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 379 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 13 | $0.00 |
| 3080F | 0% | 70 | $0.00 | |
| D0601 | 0% | 118 | $0.00 | |
| 0206 | 0% | 82 | $0.00 | |
| 86901 | 0% | 44 | $0.00 | |
| 86850 | 0% | 44 | $0.00 | |
| 0949 | 0% | 27 | $0.00 | |
| 0710 | 0% | 42 | $0.00 | |
| 0255 | 0% | 13 | $0.00 | |
| 99441 | 0% | 14 | $0.00 | |
| 3078F | 0% | 4,699 | $0.00 | |
| 84100 | 0% | 425 | $0.00 | |
| 84702 | 0% | 237 | $0.00 | |
| 3077F | 0% | 1,441 | $0.00 | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 0% | 846 | $0.00 |
| 0300 | 0% | 540 | $0.00 | |
| 0320 | 0% | 40 | $0.00 | |
| G9656 | Patient transferred directly from anesthetizing location to pacu or other non-icu location | 0% | 165 | $0.00 |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 0% | 14 | $0.00 |
| Z6304 | 0% | 279 | $0.00 | |
| 0450 | Emergency room services | 0% | 293 | $0.00 |
| 0430 | 0% | 63 | $0.00 | |
| 0521 | 0% | 110 | $0.00 | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 0% | 180 | $0.00 |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 0% | 1,001 | $0.00 |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 0% | 84 | $0.00 |
| Z6414 | 0% | 102 | $0.00 | |
| 0390 | 0% | 44 | $0.00 | |
| 99354 | 0% | 113 | $0.00 | |
| 99201 | 0% | 36 | $0.00 | |
| 0360 | 0% | 238 | $0.00 | |
| 0402 | 0% | 39 | $0.00 | |
| 0730 | 0% | 106 | $0.00 | |
| Z6300 | 0% | 14 | $0.00 | |
| 99336 | 0% | 15 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 288 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 87 | $0.00 |
| Z6200 | 0% | 41 | $0.00 | |
| 71046 | Radiologic examination, chest; 2 views | 0% | 89 | $0.00 |
| 0160 | 0% | 13 | $0.00 | |
| 92504 | 0% | 26 | $0.00 | |
| Z6202 | 0% | 70 | $0.00 | |
| 86900 | 0% | 44 | $0.00 | |
| 0121 | 0% | 13 | $0.00 | |
| 70450 | Computed tomography, head or brain; without contrast material | 0% | 24 | $0.00 |
| 91321 | 0% | 20 | $0.00 | |
| 0760 | 0% | 229 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCHURCHILL, GINA (REIMBURSEMENT DIRECTOR)
Parent organizationUC IRVINE MEDICAL CENTER
| Provider | Location | Paid |
|---|---|---|
| University of California Irvine | Anaheim, CA | $26.98M |
| University of California Irvine | Santa Ana, CA | $256K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.